Diabetes Mellitus as the Main Factor of Restenosis: Literature Review
Downloads
Background: Patients with cardiac stent have been risk of restenosis. Several studies suggest that diabetes mellitus is the factor that most consistently increases the risk of restenosis. This requires further research with the literature review to analyze the continuity of the journals found.
Methods: A literature review searched based on PRISMA, by the process of identification, screening, eligibility, and included. Journals are identified based on their focus and results. Then screening by analyzing the design, samples, variables, instruments, methods and results. Then assessed for their eligibility using The Joanna Briggs Institute (JBI) Critical Appraisal.
Results: The total number of journals that reviewed in this study is 15 journals. Six journals stated DM as a restenosis factor, two journals stated BMI as the main factor, four journals mentioned other factors and two journals denied DM was a predictor of restenosis.
Conclusion: The results of 15 journals that reviewed, diabetes mellitus was a factor that appeared consistently and had a role in the incidence of restenosis from lifestyle factors or disease history.
Anadol, R., Schnitzler, K., Lorenz, L., Weissner, M., Ullrich, H., Polimeni, A., Münzel, T., & Gori, T. (2018). Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds. BMC Cardiovascular Disorders, 18(1), 1–10. https://doi.org/10.1186/s12872-018-0811-7
Buccheri, D., Piraino, D., Andolina, G., & Cortese, B. (2016). Understanding and managing in-stent restenosis: A review of clinical data, from pathogenesis to treatment. Journal of Thoracic Disease, 8(10), E1150–E1162. https://doi.org/10.21037/jtd.2016.10.93
Daou, B., Chalouhi, N., Starke, R. M., Dalyai, R., Polifka, A., Sarkar, K., Jabbour, P., Rosenwasser, R., & Tjoumakaris, S. (2016). Predictors of restenosis after carotid artery stenting in 241 cases. Journal of NeuroInterventional Surgery, 8(7), 677–679. https://doi.org/10.1136/neurintsurg-2015-011783
Kammler, J., Blessberger, H., Lambert, T., Kellermair, J., Grund, M., Nahler, A., Lichtenauer, M., Schwarz, S., Reiter, C., Steinwender, C., & Kypta, A. (2017). In-stent restenosis after interventional treatment of carotid artery stenoses: a long-term follow-up of a single center cohort. Clinical Research in Cardiology, 106(7), 493–500. https://doi.org/10.1007/s00392-017-1078-1
Kang, J., Cho, Y. S., Kim, S. W., Park, J. J., Yoon, Y. E., Oh, I. Y., Yoon, C. H., Suh, J. W., Youn, T. J., Chae, I. H., & Choi, D. J. (2015). Intravascular ultrasound and angiographic predictors of in-stent restenosis of chronic total occlusion lesions. PLoS ONE, 10(10), 1–16. https://doi.org/10.1371/journal.pone.0140421
Konigstein, M., Ben-Yehuda, O., Smits, P. C., Love, M. P., Banai, S., Perlman, G. Y., Golomb, M., Ozan, M. O., Liu, M., Leon, M. B., Stone, G. W., & Kandzari, D. E. (2018). Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Randomized Trial. JACC: Cardiovascular Interventions, 11(24), 2467–2476. https://doi.org/10.1016/j.jcin.2018.09.033
Paramasivam, G., Devasia, T., Jayaram, A., U K, A. R., Rao, M. S., Vijayvergiya, R., & Nayak, K. (2020). In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes. Anatolian Journal of Cardiology, 23(1), 28–34. https://doi.org/10.14744/AnatolJCardiol.2019.72916
Patrick W. Serruys, MD; John D. Rutherford, M. C. (2016). The Birth, and Evolution, of Percutaneous Coronary Interventions. American Heart Association, PCI, 97–100. https://doi.org/10.1161/CIRCULATIONAHA.116.023681
Polimeni, A., Weissner, M., Schochlow, K., Ullrich, H., Indolfi, C., Dijkstra, J., Anadol, R., Münzel, T., & Gori, T. (2017). Incidence, Clinical Presentation, and Predictors of Clinical Restenosis in Coronary Bioresorbable Scaffolds. JACC: Cardiovascular Interventions, 10(18), 1819–1827. https://doi.org/10.1016/j.jcin.2017.07.034
Rai, A., Bahremand, M., Saidi, M. R., Jalili, Z., Salehi, N., Assareh, M., Abarghoei, G. A., & Kazerani, H. (2015). The Value of Pre- and Post-Stenting Fractional Flow Reserve for Predicting Mid-Term Stent Restenosis Following Percutaneous Coronary Intervention (PCI). Global Journal of Health Science, 8(7), 240–244. https://doi.org/10.5539/gjhs.v8n7p240
Ritsinger, V., Saleh, N., Lagerqvist, B., & Norhammar, A. (2015). High event rate after a first percutaneous coronary intervention in patients with diabetes mellitus. Circulation: Cardiovascular Interventions, 8(6), 1–11. https://doi.org/10.1161/CIRCINTERVENTIONS.114.002328
Ruedlinger, J., Prado, Y., Zambrano, T., Saavedra, N., Bobadilla, B., Potthoff, M., Perez, L., Lanas, F., & Salazar, L. A. (2017). CYP2C19∗2 Polymorphism in Chilean Patients with Stent Restenosis Development and Controls. BioMed Research International, 1–6. https://doi.org/https://doi.org/10.1155/2017/578371
Wan, Y. L., Tsay, P. K., Chen, C. C., Juan, Y. H., Huang, Y. C., Chan, W. H., Wen, M. S., & Hsieh, I. C. (2016). Coronary in-stent restenosis: predisposing clinical and stent-related factors, diagnostic performance and analyses of inaccuracies in 320-row computed tomography angiography. International Journal of Cardiovascular Imaging, 32, 105–115. https://doi.org/10.1007/s10554-016-0872-6
Wolny, R., Mintz, G. S., Matsumura, M., Ishida, M., Fan, Y., Fall, K. N., Parikh, M. A., Rabbani, L. R. E., Ali, Z. A., Karmpaliotis, D., Kirtane, A. J., Moses, J. W., & Maehara, A. (2019). Intravascular Ultrasound Assessment of In-Stent Restenosis in Saphenous Vein Grafts. American Journal of Cardiology, 123(7), 1052–1059. https://doi.org/10.1016/j.amjcard.2018.12.030
Yin, J., Shen, L., Ji, M., Wu, Y., Cai, S., Chen, J., Yao, Z., & Ge, J. (2017). Inverse Relationship between Serum VEGF Levels and Late In-Stent Restenosis of Drug-Eluting Stents. BioMed Research International, 2017. https://doi.org/10.1155/2017/8730271
Zhao, J., Wang, X., Wang, H., Zhao, Y., & Fu, X. (2020). Occurrence and predictive factors of restenosis in coronary heart disease patients underwent sirolimus-eluting stent implantation. Irish Journal of Medical Science, 189(3), 907–915. https://doi.org/10.1007/s11845-020-02176-9
Zhao, L., Zhu, W., Zhang, X., He, D., & Guo, C. (2017). Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis. BMC Cardiovascular Disorders, 17(1), 1-7. https://doi.org/10.1186/s12872-016-0445-6
Copyright (c) 2021 Sabila Nisak, Abu Bakar, Laily Hidayati
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution (CC BY).
Critical Medical and Surgical Nursing Journal (CMSNJ)